22 May 2013
Keywords: xolair, being, evaluated, peanut, allergy, firm, tanox
Article | 19 July 2004
US firm Tanox says that the first patient has been enrolled in a PhaseII clinical trial evaluating the safety and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 July 2004
12 July 2004
© 2013 thepharmaletter.com